Abstract #3047

Effective MR Molecular Imaging of Prostate Cancer with an EDB-Fibronectin-Specific Contrast Agent at Reduced Doses

Nadia Ayat¹, Sarah Roelle¹, Songqi Gao¹, Yajuan Li¹, and Zheng-Rong Lu¹

¹Case Western Reserve University, Cleveland, OH, United States

This research highlights the potential of a targeted contrast agent specific to the extra-domain B (EDB-FN) to be utilized in the diagnosis of prostate cancer at reduced dosages. EDB-FN specific MR contrast agent MT218 produced robust tumor enhancement at dosages as low as 0.02 mmol Gd/kg.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.